Novavax, Inc. (NVAX)

NASDAQ: NVAX · Real-Time Price · USD

8.25

+0.38 (4.83%)

At close: Feb 6, 2026, 4:00 PM EST

8.23

-0.02 (-0.29%)

After-hours: Feb 6, 2026, 4:35 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Innovative Vaccines	190.21M
Innovative Vaccines Growth	-64.20%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Europe	93.27M
Europe Growth	-65.24%
North America	65.02M
North America Growth	117.04%
Rest of the World	31.92M
Rest of the World Growth	-86.30%